Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

S.C. Johnson revising Aveeno Bath Treatment, oatmeal claims after FDA letter.

This article was originally published in The Tan Sheet

Executive Summary

S.C. JOHNSON AVEENO LABELING REVISED, COLLOIDAL OATMEAL ELIMINATED AS ACTIVE ingredient for psoriasis claims made for the company's Aveeno Bath Treatment in Regular and Oilated formulas. The company agreed to the changes in an Aug. 14 letter to FDA's Minneapolis, Minn. district office. In the letter, Racine, Wis.-based S.C. Johnson "questions as to whether or not it is permissible to make claims to `provide prompt temporary relief of itchy, sore sensitive skin due to psoriasis' under the tentative skin protectant monograph," but says it will remove the claim from inner and outer package labeling. S.C. Johnson also will submit a Drug Product Listing amendment to the agency.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel